Goiter and impairment of thyroid function in acromegalic patients: Basal evaluation and follow-up

Hormone and Metabolic Research

Volumn 32, Issue 5, 2000, Pages 190-195

  Cannavo S ^a   Squadrito, S ^a   Finocchiaro, M D ^a   Curto L ^a   Almoto, B ^a   Vieni, A ^a   Trimarchi, F ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Acromegaly; GH; Goiter; IGF 1; Iodine Deficiency; Pituitary Adenoma; TSH

Indexed keywords

GROWTH HORMONE; LIOTHYRONINE; SOMATOMEDIN BINDING PROTEIN 1; THYROTROPIN; THYROXINE;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GOITER; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IODINE DEFICIENCY; LIOTHYRONINE BLOOD LEVEL; MALE; PRIORITY JOURNAL; THYROID FUNCTION; THYROID GLAND; THYROID NODULE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0034043974     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978620     Document Type: Article

References (26)

1. 1 Mukhtar E, Alexander L, Wilkinson R, Appleton D, Hall R. Thyroid function in acromegaly. Lancet 1971; 2: 279-283
2. 2 Eskildsen PC, Kruse A, Kirkegaard C. The pituitary-thyroid axis. Horm Metab Res 1988; 20: 755-757
3. 3 Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol 1997; 46: 545-549
4. 4 Carmina E, Rosato F, Pirronello S, Janni A. Hypothalamic-pituitary-thyroid axis in acromegaly. J Endocrinol Invest 1983; 6: 263-266
5. 5 Geelhoed-Duijvestijn PH, Bussemaker JK, Roelfsema F. Changes in basal and stimulated TSH and other parameters of thyroid function in acromegaly after transsphenoidal surgery. Acta Endocrinol (Copenh) 1989; 121: 207-215
6. 6 Junik R, Sawicka J, Kozak W, Gembicki M. Thyroid volume and function in patients with acromegaly living in iodine deficient areas. J Endocrinol Invest 1997; 20: 134-137
7. 7 Lamberg BA, Pelkonen R, Aro A, Grahne B. Thyroid function in acromegaly before and after transsphenoidal hypophysectomy followed by cryoapplication. Acta Endocrinol (Copenh) 1976; 82: 254-266
8. 8 Tindall H, Wales JK. Primary hyperthyroidism occurring in association with acromegaly. Br J Clin Practice 1989; 43: 177-179
9. 9 Balkany C, Cushing GW. An association between acromegaly and thyroid carcinoma. Thyroid 1995; 5: 47-50
10. 10 Hegedus L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 1983; 56: 260-263
11. 11 Trischitta V, Damante G, Foti D, Filetti S. Insulin binding and biological activities in the FRTL-5 rat thyroid cell line. Metabolism 1987; 36: 379-383
12. 12 Delange F, Vigneri R, Trimarchi F, Filetti S, Pezzino V, Squatrito S, Bordoux P, Ermans AM. Etiological factors of endemic goiter in Northeastern Sicily. J Endocrinol Invest 1978; 1: 137-142
13. 13 Stubner D, Gartner R, Greil W, Gropper K, Brabant G, Permanetter W, Horn K, Pickardt CR. Hypertrophy and hyperplasia during goiter growth and involution in rats - separate bioeffects of TSH and iodine. Acta Endocrinol (Copenh) 1987; 116: 537-548
14. 14 Jarlov EA, Hegedus L, Gjorup T, Hansen MJ. Inadequacy of the WHO classification of the thyroid gland. Thyroidology 1992; 4: 107-110
15. 15 Brunn J, Blocjk U, Ruf J, Box I, Kunze WP, Scriba PC. Volumetrie der Schilddrüsenlappen mittels Real-Time-Sonographie. Deut Med J 1983; 287: 1206-1207
16. 16 Miyakawa M, Saji M, Tsushima T, Wakai K, Shizume K. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J Clin Endocrinol Metab 1988; 67: 973-978
17. 17 Wuster C, Steger G, Schmelzle A, Gottswinter J, Minne HW, Ziegler R. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res 1991; 23: 131-134
18. 18 Misaki T, Maciel RM, Tramontano D, Moses D, Lombardi A, Ingbar SH. Supranormal stimulation of deoxyribonucleic acid synthesis in FRTL5 cells by serum from patients with untreated acromegaly. J Clin Endocrinol Metab 1988; 66: 1227-1232
19. 19 Takahashi S, Conti M, Van Wyk JJ. Thyrotropin potentiation of insulin-like growth factors-I dependent deoxyribonucleic acid synthesis in FRTL-5 cells: Mediation by an autocrine amplification factor(s). Endocrinology 1990; 126: 736-745
20. 20 Cheung NW, Lou JC, Boyages SC. Growth hormone does not increase thyroid size in the absence of thyrotropin: a study in adults with hypopituitarism. J Clin Endocrinol Metab 1996; 81: 1179-1183
21. 21 Bray GA. Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin. J Clin Invest 1968; 47: 1640-1647
22. 22 Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 1990; 89: 602-608
23. 23 Oberhofer R, Ober A, Oberkofler F, Amor H. Thyroid gland volumes of healthy adults in an area with endemic goiter. Acta Med Austriaca 1989; 16: 38-41
24. 24 Yoshinari M, Tokuyama T, Kuroda T, Sato K, Okazawa K, Mizokami T, Okamura K, Fujishima M. Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotropin. Clin Endocrinol (Oxf) 1992; 36: 355-360
25. 25 Corrigan DF, Wartofsky L, Dimond RC, Schaaf M, Earll JM, Rogers JE, Wright FD, Burman KD. Parameters of thyroid function in patients with active acromegaly. Metabolism 1978; 27: 209-216
26. 26 Ain K, Taylor K. Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 1994; 78: 1097-1102